Talphera (TLPH) Long-Term Deferred Tax (2017 - 2018)

Talphera (TLPH) posted quarterly Long-Term Deferred Tax of $351000.0 for Q3 2018, little changed quarter-over-quarter from $351000.0 in Q2 2018.

Talphera (TLPH) Long-Term Deferred Tax (2017 - 2018) Analysis & Trends

Talphera's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $351000.0 for Q3 2018.

In Q3 2018, Long-Term Deferred Tax changed N/A year-over-year to $351000.0; the TTM figure through Sep 2018 stood at $351000.0 (changed N/A YoY), while the FY2017 annual figure was $703000.0, changed N/A from the prior year.
Long-Term Deferred Tax for Q3 2018 stood at $351000.0, roughly flat from $351000.0 in the prior quarter.
The five-year high for Long-Term Deferred Tax was $703000.0 in Q4 2017, with the low at $351000.0 in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-
2	Teva Pharmaceutical Industries	43.08 Bn	39.43 Bn	2.15 Bn
3	Zoetis	31.54 Bn	29.87 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn
5	United Therapeutics	22.12 Bn	19.46 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-
10	Talphera	90.25 Mn	90.25 Mn	-

Download Data